Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for antifungal drug Efinaconazole Topical Solution, ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
The Board of Directors at their meeting held on 6th May, 2025 has recommended Dividend of H11/- (550%) per equity share having face value of H2/- each for the financial year 2024-25 which is the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results